Ledger.Open graph →
SEC Form D · filed May 13, 2024

Aeovian Pharmaceuticals, Inc

Offering
$50.4M
Sold
$50.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Berkeley, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Nils J. Regge · Berkeley, CADirectorLars C. Ekm · Berkeley, CADirectorMatthew J. Plunkett · Berkeley, CAExecAlex M. Page · New York, NYDirectorJohn J. Kincaid · Berkeley, CAExecRichard J. Gaster · Berkeley, CADirectorRichard J. Gaster · Berkeley, CADirectorDavis J. Ryman · Berkeley, CAExecAllison J. Hulme · Berkeley, CAExec · DirectorWilliam J. Greene · Berkeley, CADirectorLars C. Ekm · Berkeley, CADirectorRima C. Simson · New York, NYExecWilliam J. Greene · Berkeley, CADirectorScott Carson · Park City, UTDirectorAllison J. Hulme · Berkeley, CAExec · DirectorJohn J. Kincaid · Berkeley, CAExecMark Attanasio · Culver City, CADirectorRob Mlenek · Bloomington, MNExecDavis J. Ryman · Berkeley, CAExecMatthew J. Plunkett · Berkeley, CAExecNils J. Regge · Berkeley, CADirectorDavid Licata · Culver City, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗